Tenet Healthcare Corporat... (THC)
NYSE: THC
· Real-Time Price · USD
172.03
-0.33 (-0.19%)
At close: Aug 15, 2025, 3:59 PM
171.00
-0.60%
After-hours: Aug 15, 2025, 06:00 PM EDT
Tenet Healthcare Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.27B | 5.22B | 5.07B | 5.12B | 5.1B | 5.37B | 5.38B | 5.07B | 5.08B | 5.02B | 4.99B | 4.8B | 4.64B | 4.75B | 4.86B | 4.89B | 4.95B | 4.78B |
Cost of Revenue | 4.42B | 2.12B | 930M | 3.33B | 4.43B | 4.61B | 4.66B | 877M | 891M | 891M | 860M | 817M | 811M | 785M | 838M | 827M | 859M | 804M |
Gross Profit | 852M | 3.1B | 4.14B | 1.79B | 671M | 757M | 721M | 4.19B | 4.19B | 4.13B | 4.13B | 3.98B | 3.83B | 3.96B | 4.02B | 4.07B | 4.09B | 3.98B |
Operating Income | 852M | 943M | 821M | 1.09B | 671M | 757M | 721M | 568M | 604M | 603M | 536M | 596M | 553M | 648M | 751M | 1.01B | 586M | 520M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 642M | 765M | 655M | 922M | 587M | 3.08B | 519M | 345M | 373M | 380M | 321M | 380M | 265M | 378M | 528M | 774M | 319M | 267M |
Net Income | 288M | 406M | 318M | 472M | 259M | 2.15B | 244M | 101M | 123M | 296M | 274M | 268M | 179M | 279M | 249M | 449M | 119M | 97M |
Selling & General & Admin | 2.16B | 2.12B | 2.09B | 2.22B | 2.17B | 2.32B | 2.31B | 2.29B | 2.29B | 2.26B | 2.31B | 2.23B | 2.13B | 2.18B | 2.19B | 2.21B | 2.28B | 2.2B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -2.16B | 42M | 1.23B | -1.51B | 29M | 2.32B | 11M | 4M | 6M | 1.31B | 1.21B | 1.17B | 1.13B | 1.14B | -2M | 7M | -1M | 10M |
Operating Expenses | n/a | 2.16B | 3.32B | 704M | 3.52B | 3.68B | 3.73B | 3.61B | 3.62B | 3.56B | 3.51B | 3.4B | 3.25B | 3.32B | 3.28B | 3.47B | 3.54B | 3.47B |
Interest Expense | 206M | 204M | 203M | 202M | 203M | 218M | 227M | 227M | 226M | 221M | 219M | 222M | 222M | 227M | 221M | 227M | 235M | 240M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.42B | 4.28B | 4.25B | 4.03B | 4.43B | 4.61B | 4.66B | 4.49B | 4.51B | 4.46B | 4.37B | 4.22B | 4.07B | 4.11B | 4.12B | 4.29B | 4.39B | 4.27B |
Income Tax Expense | 120M | 143M | 83M | 241M | 110M | 750M | 63M | 79M | 80M | 84M | 47M | 112M | 86M | 99M | 108M | 197M | 61M | 45M |
Shares Outstanding (Basic) | 91.14M | 94.24M | 95.1M | 95.67M | 97.27M | 99.58M | 100.96M | 101.54M | 101.77M | 102.29M | 104.52M | 107.92M | 107.79M | 107.48M | 107.15M | 107.05M | 106.82M | 106.31M |
Shares Outstanding (Diluted) | 91.79M | 95.02M | 95.88M | 96.65M | 98.44M | 100.6M | 104.17M | 104.42M | 104.78M | 106.01M | 106.37M | 109.89M | 108.75M | 112.02M | 108.89M | 108.76M | 108.57M | 108.06M |
EPS (Basic) | 3.16 | 4.31 | 3.34 | 4.94 | 2.66 | 21.60 | 2.42 | 0.99 | 1.21 | 2.89 | 2.62 | 2.48 | 1.66 | 2.60 | 2.32 | 4.19 | 1.11 | 0.91 |
EPS (Diluted) | 3.14 | 4.27 | 3.32 | 4.89 | 2.64 | 21.38 | 2.34 | 0.97 | 1.17 | 2.79 | 2.58 | 2.44 | 1.65 | 2.49 | 2.29 | 4.13 | 1.10 | 0.90 |
EBITDA | 1.06B | 1.18B | 1.05B | 1.33B | 882M | 1.03B | 1.05B | 796M | 787M | 970M | 984M | 689M | 692M | 846M | 884M | 805M | 758M | 795M |
EBIT | 848M | 969M | 858M | 1.12B | 674M | 825M | 838M | 564M | 574M | 753M | 771M | 480M | 476M | 643M | 683M | 596M | 537M | 571M |
Depreciation & Amortization | 208M | 206M | 193M | 209M | 208M | 208M | 216M | 224M | 213M | 217M | 213M | 209M | 216M | 203M | 201M | 209M | 221M | 224M |